CN102026658A - 改进的免疫组合物 - Google Patents

改进的免疫组合物 Download PDF

Info

Publication number
CN102026658A
CN102026658A CN2008801269094A CN200880126909A CN102026658A CN 102026658 A CN102026658 A CN 102026658A CN 2008801269094 A CN2008801269094 A CN 2008801269094A CN 200880126909 A CN200880126909 A CN 200880126909A CN 102026658 A CN102026658 A CN 102026658A
Authority
CN
China
Prior art keywords
antigen
composition
protein
polypeptide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2008801269094A
Other languages
English (en)
Chinese (zh)
Inventor
B·古斯
J-I·弗洛克
L·弗里克伯格
M·弗洛克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervacc AB
Original Assignee
Intervacc AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervacc AB filed Critical Intervacc AB
Publication of CN102026658A publication Critical patent/CN102026658A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CN2008801269094A 2007-12-13 2008-12-12 改进的免疫组合物 Pending CN102026658A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US1349507P 2007-12-13 2007-12-13
US61/013495[32]2007.12.13[33]US 2007-12-13
US8228108P 2008-07-21 2008-07-21
US61/082281[32]2008.07.21[33]US 2008-07-21
PCT/SE2008/051445 WO2009075646A1 (en) 2007-12-13 2008-12-12 Improved immunizing composition

Publications (1)

Publication Number Publication Date
CN102026658A true CN102026658A (zh) 2011-04-20

Family

ID=40755754

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008801269094A Pending CN102026658A (zh) 2007-12-13 2008-12-12 改进的免疫组合物

Country Status (8)

Country Link
US (2) US20110020403A1 (enExample)
EP (1) EP2227249B1 (enExample)
JP (1) JP2011506433A (enExample)
CN (1) CN102026658A (enExample)
AU (1) AU2008336295B2 (enExample)
CA (1) CA2708260A1 (enExample)
NZ (1) NZ586367A (enExample)
WO (1) WO2009075646A1 (enExample)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106561082A (zh) * 2014-05-30 2017-04-12 爱蒂特生物制药有限公司 抗猪链球菌感染的疫苗组合物
CN107532156A (zh) * 2015-02-12 2018-01-02 汉莎医药有限公司 半胱氨酸蛋白酶
CN113564150A (zh) * 2015-02-12 2021-10-29 汉莎生物制药股份有限公司 半胱氨酸蛋白酶
WO2021254479A1 (zh) * 2020-06-18 2021-12-23 上海宝济药业有限公司 一种免疫球蛋白降解酶IdeE的突变体
CN114437235A (zh) * 2022-01-04 2022-05-06 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用
WO2023116817A1 (zh) * 2021-12-22 2023-06-29 上海宝济药业有限公司 一种免疫球蛋白降解酶IdeE的突变体的用途
CN118497176A (zh) * 2024-07-16 2024-08-16 苏州康聚生物科技有限公司 一种免疫球蛋白降解酶

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2498812A4 (en) * 2009-11-13 2013-05-22 Bengt Guss IMMUNIZATION COMPOSITION FOR REDUCING STREPTOCOCCAL INFECTIONS
EP3135684B1 (en) 2010-05-26 2023-06-28 Intervacc AB Vaccine against streptococcal infections based on recombinant fusion proteins
CN117042805A (zh) * 2021-04-05 2023-11-10 株式会社Lg化学 对抗冠状病毒的疫苗组合物
US12091694B2 (en) 2022-11-18 2024-09-17 Seismic Therapeutic, Inc. Fc fusion molecules and uses thereof
EP4646476A1 (en) 2023-01-06 2025-11-12 Seismic Therapeutic, Inc. Protease variants and uses thereof
WO2025054602A1 (en) * 2023-09-08 2025-03-13 The Texas A&M University System Protein for the serological detection of streptococcus equi subspecies equi exposure or infection

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241545A1 (es) 1985-07-12 1992-08-31 Cornell Res Foundation Inc Un metodo para preparar una cepa de s. equi avirulenta a.t.c.c. 53186 para equinos.
US5583014A (en) 1990-07-03 1996-12-10 Bayer Corporation Preparation and use of enzyme-detergent extracted Streptococcus zoopidemicus vaccine
SE9003374D0 (sv) 1990-10-22 1990-10-22 Alfa Laval Agri Int A collagen binding protein as well as its preparation
SE9302855D0 (sv) 1993-09-06 1993-09-06 Martin Lindberg Method and means for producing plasmaproteinase inhibitor binding proteins
IES960488A2 (en) 1996-07-03 1997-11-19 Trinity College Dublin Subunit Vaccine for Streptococcus Equi
CA2243730C (en) * 1997-07-29 2009-12-22 Akzo Nobel N.V. Streptococcus equi vaccine
SE9804491D0 (sv) 1998-12-22 1998-12-22 Bengt Guss Novel fibronectin-binding protein
US6887480B1 (en) 1999-06-10 2005-05-03 Medimmune, Inc. Streptococcus pneumoniae proteins and vaccines
ES2264419T3 (es) * 1999-06-10 2007-01-01 Medimmune, Inc. Vacunas y proteinas de streptococcus pneumoniae.
US8404245B2 (en) * 2002-10-11 2013-03-26 Intervacc Ab Immunization of non-human mammals against Streptococcus equi
AU2007233252C1 (en) * 2006-03-29 2013-05-23 Boehringer Ingelheim Animal Health USA Inc. Vaccine against Streptococci

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106561082B (zh) * 2014-05-30 2021-08-03 诗华动物保健公司 抗猪链球菌感染的疫苗组合物
CN113769076A (zh) * 2014-05-30 2021-12-10 诗华动物保健公司 抗猪链球菌感染的疫苗组合物
CN106561082A (zh) * 2014-05-30 2017-04-12 爱蒂特生物制药有限公司 抗猪链球菌感染的疫苗组合物
CN113564150B (zh) * 2015-02-12 2024-09-17 汉莎生物制药股份有限公司 半胱氨酸蛋白酶
CN107532156A (zh) * 2015-02-12 2018-01-02 汉莎医药有限公司 半胱氨酸蛋白酶
CN113564150A (zh) * 2015-02-12 2021-10-29 汉莎生物制药股份有限公司 半胱氨酸蛋白酶
WO2021254479A1 (zh) * 2020-06-18 2021-12-23 上海宝济药业有限公司 一种免疫球蛋白降解酶IdeE的突变体
CN115443288A (zh) * 2020-06-18 2022-12-06 上海宝济药业有限公司 一种免疫球蛋白降解酶IdeE的突变体
WO2023116817A1 (zh) * 2021-12-22 2023-06-29 上海宝济药业有限公司 一种免疫球蛋白降解酶IdeE的突变体的用途
US12319942B2 (en) 2021-12-22 2025-06-03 Shanghai Bao Pharmaceuticals Co., Ltd. Use of mutant of immunoglobulin degrading enzyme IdeE
CN114437235A (zh) * 2022-01-04 2022-05-06 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用
CN114437235B (zh) * 2022-01-04 2024-02-09 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种8种蛋白的重组融合蛋白及其制备方法和应用
CN118497176A (zh) * 2024-07-16 2024-08-16 苏州康聚生物科技有限公司 一种免疫球蛋白降解酶

Also Published As

Publication number Publication date
EP2227249A4 (en) 2011-08-31
WO2009075646A1 (en) 2009-06-18
EP2227249A1 (en) 2010-09-15
CA2708260A1 (en) 2009-06-18
EP2227249B1 (en) 2018-04-25
AU2008336295A1 (en) 2009-06-18
US20140220064A1 (en) 2014-08-07
US20110020403A1 (en) 2011-01-27
JP2011506433A (ja) 2011-03-03
AU2008336295B2 (en) 2013-07-11
NZ586367A (en) 2012-04-27
US9987342B2 (en) 2018-06-05

Similar Documents

Publication Publication Date Title
CN102026658A (zh) 改进的免疫组合物
Opriessnig et al. Erysipelothrix spp.: past, present, and future directions in vaccine research
Timoney The pathogenic equine streptococci
EP2590994B1 (en) Vaccine against streptococcal infections based on recombinant proteins
Crouch et al. Cross protection of a Mannheimia haemolytica A1 Lkt-/Pasteurella multocida ΔhyaE bovine respiratory disease vaccine against experimental challenge with Mannheimia haemolytica A6 in calves
Ntombela et al. Production of recombinant lumpy skin disease virus A27L and L1R proteins for application in diagnostics and vaccine development
CN109456393A (zh) 肺炎链球菌蛋白在抗肺炎链球菌感染中的应用
Guzmán-Brambila et al. Two outer membrane lipoproteins from Histophilus somni are immunogenic in rabbits and sheep and induce protection against bacterial challenge in mice
ES2684556T3 (es) Vacunas de mannheimia haemolytica atenuadas y procedimientos de fabricación y uso
Li et al. Study on preparation of a Streptococcus suis ghost vaccine
CN109106946B (zh) 一种奶牛乳房炎金黄色葡萄球菌灭活疫苗及其制备方法
Camussone et al. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant
CN104248754A (zh) 猪链球菌疫苗组合物及其制备方法和应用
CN116284274A (zh) 一种重组猪丹毒杆菌表面抗原SpaA蛋白及其应用
CN113354742A (zh) 一种布鲁氏杆菌基因工程亚单位疫苗及其制备方法和应用
De Negri Equine Serum Antibody Responses to Streptococcus Equi and Streptococcus Zooepidemicus
HK1156230A (en) Improved immunizing composition
Cohen et al. Immunization but not natural infection of horses results in antibody activity against the S protein of Streptococcus equi subsp equi
Manning Investigating alternative strategies for the prevention of pneumococcal colonisation and disease.
Byeon et al. Generation of an attenuated Salmonella-delivery strains expressing adhesin and toxin antigens for progressive atrophic rhinitis, and evaluation of its immune responses in a murine model
Muthupalani Characterization, immunogenicity and possible roles of Streptococcus equi Linkage Group I proteins in the pathogenesis of strangles
CN115433723A (zh) 预防革兰氏阳性致病菌的重组蛋白、疫苗、药物
Samuel et al. Genomic and Proteomic Approaches Against Q Fever
Flock Development of a Vaccine against Strangles
Lantz Investigations into the Use of the M-protein for the Production of a Vaccine Against Streptococcus equi Subspecies equi Using Chicken IgY

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1156230

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110420

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1156230

Country of ref document: HK